Citations 166

F4‐02‐04: The Alzheimer's Prevention Initiative (API) Program: Genetic Testing and Disclosure Strategies

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_6 | Pages: No page available

10.1016/j.jalz.2016.06.595

P2‐243: Higher BMI is Associated with Greater Cerebral Glucose Metabolism in Late Middle‐Aged and Elderly Subjects Regardless of APOE ε4 Genotype

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2016.06.1411

P4‐149: Peripheral Apoe Levels are Associated with Regional Gray Matter Volume, Cerebral Glucose Metabolism and Cognitive Performance in Cognitively Normal APOE E3/4 Carriers

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_22 | Pages: No page available

10.1016/j.jalz.2016.06.2240

P3‐285: Patch‐Based Sparse Coding and Multivariate Surface Morphometry for Predicting Amnestic Mild Cognitive Impairment and Alzheimer’S Disease in Cognitively Unimpaired Individuals

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_19 | Pages: No page available

10.1016/j.jalz.2016.06.1939

A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases

Alzheimer Disease & Associated Disorders | January 12, 2016 | Volume: 30 | Issue: 3 | Pages: 223-229

10.1097/wad.0000000000000138 | PMID 26756386

Studies have demonstrated associations between cardiovascular factors and Alzheimer disease (AD) with minimal focus on other neurodegenerative diseases. Utilizing cross-sectional data from 17,532 individuals in the National Alzheimer’s Coordinating Center, Uniform Data Set, we compared the presence of cardiovascular factors [body mass index (BMI), atrial fibrillation, hypertension, hyperlipidemia, and diabetes] in individuals carrying a diagnosis of Probable AD (ProbAD), Possible AD, vascular dementia, dementia with Lewy bodies (DLB), frontotemporal dementia, Parkinson disease, progressive supranuclear palsy, or corticobasal degeneration, with that of normals. Generalized linear mixed models were fitted with age at visit, gender, and cardiovascular factors as fixed effects and Alzheimer’s Disease Centers as random effects. In late life, only BMI of ProbAD and DLB patients was statistically significantly lower than that in normals (P–values <0.001). When accounting for colinearity within cardiovascular factors, a low BMI was a comorbidity of certain dementia etiologies as compared with normals. These data support a concept of disease-specific associations with certain cardiovascular factors.
P3‐169: Reduced default network functional connectivity and verbal learning in cognitively unimpaired late middle‐aged and older adults: Exploratory findings from the arizona ApoE cohort study

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_15 | Pages: No page available

10.1016/j.jalz.2015.06.1540

F3‐03‐04: The Alzheimer's prevention initiative: Genetic testing, disclosure, and counseling strategies

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_5 | Pages: No page available

10.1016/j.jalz.2015.07.233

P1‐319: Alzheimer's prevention registry: A shared resource to the scientific community to facilitate enrollment in studies

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_10 | Pages: No page available

10.1016/j.jalz.2015.06.534

P4‐053: Memory, executive, and multi‐domain subtle cognitive impairment: Clinical and biomarker finding

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_17 | Pages: No page available

10.1016/j.jalz.2015.06.1758

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques

JAMA Neurology | August 24, 2015 | Volume: 72 | Issue: 10 | Pages: 1124

10.1001/jamaneurol.2015.1721 | PMID 26302353